The pursuit of sustainable, low-calorie sweeteners has intensified interest in the biosynthesis of rare sugars such as tagatose from fructose. Tagatose, a C-7 epimer of fructose, occurs naturally in small amounts in dairy products and fruits, but its growing demand as a functional sweetener with a glycemic index near zero has triggered innovative biotechnological approaches. In the United States, patent applications focusing on the conversion of fructose to tagatose often center on metabolic engineering, enzymatic cascades, and microbial fermentation platforms designed to maximize yield, reduce production costs, and meet food-grade purity standards. These innovations not only reshape the sweetener landscape but also offer a pathway toward circular bioeconomy models that valorize fructose streams from corn, sucrose hydrolysis, or agricultural waste That's the part that actually makes a difference..
You'll probably want to bookmark this section.
The chemical distinction between fructose and tagatose lies in the spatial arrangement of the hydroxyl group at the second carbon position. While both are ketohexoses, tagatose exhibits a pyranose ring preference and demonstrates significantly lower impact on blood glucose levels, making it an attractive alternative for diabetic-friendly and keto-formulated products. Worth adding, tagatose possesses a sweetness profile approximately 90% that of sucrose, with a clean, rapid onset and no lingering aftertaste—qualities that have positioned it as a flagship ingredient in
Not obvious, but once you see it — you'll see it everywhere Still holds up..